{"result": {"id": "496dcb6e-a31c-4617-906a-e6a21ed16cd5", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**伊曲康唑（Itraconazole）** 是一种三唑类抗真菌药物，通过抑制真菌细胞膜中麦角固醇的合成发挥抗菌作用。作为强效的CYP3A4酶和P-糖蛋白（P-gp）抑制剂，伊曲康唑可显著影响多种药物的代谢，导致其血药浓度升高，增加不良反应风险。  \n\n伊曲康唑对CYP3A4的抑制作用尤为突出，可减缓经该酶代谢的药物清除，包括：  \n1. **抗凝药物**：如达比加群酯（dabigatran etexilate）和利伐沙班（rivaroxaban），其血药浓度可能因伊曲康唑的抑制作用而升高，增加出血风险。  \n2. **镇静药物**：如唑吡坦（zolpidem），代谢受阻可能导致中枢神经系统抑制效应增强。  \n3. **钙通道阻滞剂（CCB）**：如氨氯地平等，伊曲康唑可减慢其代谢，增强降压效果及潜在副作用（如低血压、水肿）。  \n4. **他汀类药物**：如阿托伐他汀和辛伐他汀，伊曲康唑可显著增加其血药浓度，进而升高横纹肌溶解和肝毒性风险。  \n\n此外，伊曲康唑对CYP450酶系统的广泛抑制进一步扩大了其药物相互作用范围。临床使用时应密切监测合并用药的剂量及不良反应，必要时调整方案以避免毒性。  \n\n综上，伊曲康唑既是重要的抗真菌药物，也是需谨慎管理的CYP3A4/P-gp抑制剂，其药物相互作用涉及心血管、神经、代谢等多领域，需在联合用药时严格评估风险收益比。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752167524, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 366, "prompt_tokens": 279, "total_tokens": 645, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 215}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"伊曲康唑\"\nDescription List: [\"Itraconazole is a strong CYP3A4 and P-gp inhibitor that increases drug concentrations of dabigatran etexilate and rivaroxaban\\\"\", \"Itraconazole is a strong CYP3A4 inhibitor that can increase zolpidem concentrations\", \"伊曲康唑是一种CYP3A4强抑制剂，能减慢CCB类药物的代谢\", \"伊曲康唑是一种三唑类抗真菌药物，抑制CYP450酶系统>\", \"伊曲康唑是一种抗真菌药物，可抑制CYP3A4，减慢阿托伐他汀和辛伐他汀的代谢，增加肌肉和肝脏毒性>\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_1b77b3a04ab6c3ab901b9b603b15b3c2aca4ec925942e4070a89634b72ff40fe_v2"}